Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1987-10-16
pubmed:abstractText
Eight samples of human liver have been characterised for microsomal protein content, cytochrome P-450 content, tolbutamide 4-hydroxylase and ethinyloestradiol 2-hydroxylase activities. Cytochrome P-450 content correlated significantly with ethinyloestradiol 2-hydroxylase activity but not with tolbutamide 4-hydroxylase activity. There was no significant correlation between ethinyloestradiol 2-hydroxylase and tolbutamide 4-hydroxylase activities. The maximum tolbutamide 4-hydroxylase activity was 0.45 nmol min-1 mg-1 microsomal protein, with a Km value of 74 microM. A number of compounds were tested for their ability to inhibit tolbutamide metabolism. All the compounds showing inhibition were either non-competitive or mixed non-competitive inhibitors of tolbutamide 4-hydroxylation. These studies suggest that tolbutamide is metabolised by an isozyme of cytochrome P-450 which appears to be distinct from those isozymes metabolising many other drugs.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-14071924, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-14209971, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-3555579, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-3724146, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-3739363, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-401727, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-4027115, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-448864, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-5014495, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-5968015, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-6121708, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-6147254, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-6488689, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-6626444, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-6697063, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-7042170, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-7213514, http://linkedlifedata.com/resource/pubmed/commentcorrection/3620298-913025
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
230-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1987
pubmed:articleTitle
Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors.
pubmed:publicationType
Journal Article, In Vitro